Bei-Bei Cui M.D., Jun He M.D., Hong-Liang Yao M.D.
{"title":"代谢减肥手术后的自杀风险:配对队列研究和人群研究的荟萃分析。","authors":"Bei-Bei Cui M.D., Jun He M.D., Hong-Liang Yao M.D.","doi":"10.1016/j.soard.2024.10.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Metabolic bariatric surgery (MBS) remains the optimal treatment for patients with severe obesity. However, concern is growing about the risk of suicide after MBS.</div></div><div><h3>Objectives</h3><div>To compare the risk of suicide in adult patients with obesity, treated with or without MBS.</div></div><div><h3>Setting</h3><div>University-affiliated hospital, China.</div></div><div><h3>Methods</h3><div>PubMed and Embase were searched through April 30, 2024. Eligible studies were matched cohort studies and population-based studies (PROSPERO ID: CRD42024561042). Effects were pooled using a random-effects model. Subgroup analysis was performed based on study type.</div></div><div><h3>Results</h3><div>A total of 3 matched cohort studies (4 matched cohorts) and 2 population-based studies, involving 114,615 adult patients with obesity treated with MBS (272 suicides) and 552,642 nonsurgery counterparts (622 suicides), met the selection criteria. Patients treated with MBS had a pooled hazard ratio (HR) of suicide of 2.12 (95% confidence interval [CI] 1.54−2.92, <em>P</em> < .01, <em>I</em><sup><em>2</em></sup> = 24%) and a pooled risk ratio (RR) of suicide of 2.32 (95% CI 1.55−3.45, <em>P</em> < .01, <em>I</em><sup><em>2</em></sup> = 58%) compared with those treated without MBS. In the subgroup analysis, relatively higher pooled HR (2.64 [1.84−3.77] versus 1.67 [1.32−2.12]) and RR (2.98 [2.02−4.41] versus 1.48 [.80−2.75]) were observed in the subgroup of matched cohort studies compared with the subgroup of population-based studies.</div></div><div><h3>Conclusions</h3><div>Adult patients treated with MBS are at more than double the risk of suicide than those treated without MBS in terms of both HR and RR. However, the absolute risk was low and did not warrant a general discouragement of MBS.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"21 1","pages":"Pages 67-75"},"PeriodicalIF":3.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Risk of suicide after metabolic bariatric surgery: a meta-analysis of matched cohort studies and population-based studies\",\"authors\":\"Bei-Bei Cui M.D., Jun He M.D., Hong-Liang Yao M.D.\",\"doi\":\"10.1016/j.soard.2024.10.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Metabolic bariatric surgery (MBS) remains the optimal treatment for patients with severe obesity. However, concern is growing about the risk of suicide after MBS.</div></div><div><h3>Objectives</h3><div>To compare the risk of suicide in adult patients with obesity, treated with or without MBS.</div></div><div><h3>Setting</h3><div>University-affiliated hospital, China.</div></div><div><h3>Methods</h3><div>PubMed and Embase were searched through April 30, 2024. Eligible studies were matched cohort studies and population-based studies (PROSPERO ID: CRD42024561042). Effects were pooled using a random-effects model. Subgroup analysis was performed based on study type.</div></div><div><h3>Results</h3><div>A total of 3 matched cohort studies (4 matched cohorts) and 2 population-based studies, involving 114,615 adult patients with obesity treated with MBS (272 suicides) and 552,642 nonsurgery counterparts (622 suicides), met the selection criteria. Patients treated with MBS had a pooled hazard ratio (HR) of suicide of 2.12 (95% confidence interval [CI] 1.54−2.92, <em>P</em> < .01, <em>I</em><sup><em>2</em></sup> = 24%) and a pooled risk ratio (RR) of suicide of 2.32 (95% CI 1.55−3.45, <em>P</em> < .01, <em>I</em><sup><em>2</em></sup> = 58%) compared with those treated without MBS. In the subgroup analysis, relatively higher pooled HR (2.64 [1.84−3.77] versus 1.67 [1.32−2.12]) and RR (2.98 [2.02−4.41] versus 1.48 [.80−2.75]) were observed in the subgroup of matched cohort studies compared with the subgroup of population-based studies.</div></div><div><h3>Conclusions</h3><div>Adult patients treated with MBS are at more than double the risk of suicide than those treated without MBS in terms of both HR and RR. However, the absolute risk was low and did not warrant a general discouragement of MBS.</div></div>\",\"PeriodicalId\":49462,\"journal\":{\"name\":\"Surgery for Obesity and Related Diseases\",\"volume\":\"21 1\",\"pages\":\"Pages 67-75\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgery for Obesity and Related Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1550728924008554\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery for Obesity and Related Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1550728924008554","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
Risk of suicide after metabolic bariatric surgery: a meta-analysis of matched cohort studies and population-based studies
Background
Metabolic bariatric surgery (MBS) remains the optimal treatment for patients with severe obesity. However, concern is growing about the risk of suicide after MBS.
Objectives
To compare the risk of suicide in adult patients with obesity, treated with or without MBS.
Setting
University-affiliated hospital, China.
Methods
PubMed and Embase were searched through April 30, 2024. Eligible studies were matched cohort studies and population-based studies (PROSPERO ID: CRD42024561042). Effects were pooled using a random-effects model. Subgroup analysis was performed based on study type.
Results
A total of 3 matched cohort studies (4 matched cohorts) and 2 population-based studies, involving 114,615 adult patients with obesity treated with MBS (272 suicides) and 552,642 nonsurgery counterparts (622 suicides), met the selection criteria. Patients treated with MBS had a pooled hazard ratio (HR) of suicide of 2.12 (95% confidence interval [CI] 1.54−2.92, P < .01, I2 = 24%) and a pooled risk ratio (RR) of suicide of 2.32 (95% CI 1.55−3.45, P < .01, I2 = 58%) compared with those treated without MBS. In the subgroup analysis, relatively higher pooled HR (2.64 [1.84−3.77] versus 1.67 [1.32−2.12]) and RR (2.98 [2.02−4.41] versus 1.48 [.80−2.75]) were observed in the subgroup of matched cohort studies compared with the subgroup of population-based studies.
Conclusions
Adult patients treated with MBS are at more than double the risk of suicide than those treated without MBS in terms of both HR and RR. However, the absolute risk was low and did not warrant a general discouragement of MBS.
期刊介绍:
Surgery for Obesity and Related Diseases (SOARD), The Official Journal of the American Society for Metabolic and Bariatric Surgery (ASMBS) and the Brazilian Society for Bariatric Surgery, is an international journal devoted to the publication of peer-reviewed manuscripts of the highest quality with objective data regarding techniques for the treatment of severe obesity. Articles document the effects of surgically induced weight loss on obesity physiological, psychiatric and social co-morbidities.